SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 1-A/A - Offering Statement [Regulation A]: [Amend]
SEC Accession No. 0001683168-18-003041
Filing Date
2018-10-12
Accepted
2018-10-12 17:09:26
Documents
6

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A/A  
1 primary_doc.xml 1-A/A 15095
2 PRELIMINARY OFFERING CIRCULAR cns_1aa2-poc.htm PART II AND III 877901
3 FORM OF ISSUER ACKNOWLEDGMENT REGULATION A OFFERING BETWEEN CNS PHARMACEUTICALS, cns_1aa2-ex0102.htm EX1A-1 UNDR AGMT 218581
4 FORM OF OFFERING DEPOSIT ACCOUNT AGENCY AGREEMENT WITH FINTECH CLEARING, LLC cns_1aa2-ex0801.htm EX1A-8 ESCW AGMT 121004
5 CONSENT cns_1aa2-ex1101.htm EX1A-11 CONSENT 2318
6 TERMS OF USE - FLASHFUNDERS.COM cns_1aa2-ex1501.htm EX1A-14 CNSNT SV 142090
  Complete submission text file 0001683168-18-003041.txt   1378083
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 1-A/A | Act: 33 | File No.: 024-10855 | Film No.: 181120787
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1